Hyundai ADM Bio Statistics
Total Valuation
Hyundai ADM Bio has a market cap or net worth of KRW 73.62 billion. The enterprise value is 76.87 billion.
Market Cap | 73.62B |
Enterprise Value | 76.87B |
Important Dates
The last earnings date was Monday, March 17, 2025.
Earnings Date | Mar 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Hyundai ADM Bio has 42.29 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 42.29M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.75% |
Owned by Institutions (%) | n/a |
Float | 27.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.56 |
PB Ratio | 10.79 |
P/TBV Ratio | 11.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.83 |
EV / Sales | 7.89 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.36 |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 1.40.
Current Ratio | 0.55 |
Quick Ratio | 0.35 |
Debt / Equity | 1.40 |
Debt / EBITDA | n/a |
Debt / FCF | -0.65 |
Interest Coverage | -13.69 |
Financial Efficiency
Return on equity (ROE) is -88.95% and return on invested capital (ROIC) is -39.46%.
Return on Equity (ROE) | -88.95% |
Return on Assets (ROA) | -27.49% |
Return on Invested Capital (ROIC) | -39.46% |
Return on Capital Employed (ROCE) | -200.38% |
Revenue Per Employee | 60.91M |
Profits Per Employee | -125.60M |
Employee Count | 160 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.79% in the last 52 weeks. The beta is 1.06, so Hyundai ADM Bio's price volatility has been similar to the market average.
Beta (5Y) | 1.06 |
52-Week Price Change | +3.79% |
50-Day Moving Average | 2,054.36 |
200-Day Moving Average | 1,737.57 |
Relative Strength Index (RSI) | 43.10 |
Average Volume (20 Days) | 1,562,450 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hyundai ADM Bio had revenue of KRW 9.74 billion and -20.10 billion in losses. Loss per share was -475.02.
Revenue | 9.74B |
Gross Profit | 57.97M |
Operating Income | -15.99B |
Pretax Income | -18.23B |
Net Income | -20.10B |
EBITDA | -14.41B |
EBIT | -15.99B |
Loss Per Share | -475.02 |
Balance Sheet
The company has 5.84 billion in cash and 9.29 billion in debt, giving a net cash position of -3.44 billion or -81.46 per share.
Cash & Cash Equivalents | 5.84B |
Total Debt | 9.29B |
Net Cash | -3.44B |
Net Cash Per Share | -81.46 |
Equity (Book Value) | 6.63B |
Book Value Per Share | 161.33 |
Working Capital | -9.23B |
Cash Flow
In the last 12 months, operating cash flow was -14.29 billion and capital expenditures -53.88 million, giving a free cash flow of -14.35 billion.
Operating Cash Flow | -14.29B |
Capital Expenditures | -53.88M |
Free Cash Flow | -14.35B |
FCF Per Share | -339.27 |
Margins
Gross margin is 0.59%, with operating and profit margins of -164.13% and -206.22%.
Gross Margin | 0.59% |
Operating Margin | -164.13% |
Pretax Margin | -187.09% |
Profit Margin | -206.22% |
EBITDA Margin | -147.82% |
EBIT Margin | -164.13% |
FCF Margin | n/a |
Dividends & Yields
Hyundai ADM Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -27.30% |
FCF Yield | -19.49% |
Stock Splits
The last stock split was on November 27, 2024. It was a forward split with a ratio of 2.
Last Split Date | Nov 27, 2024 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Hyundai ADM Bio has an Altman Z-Score of -0.68. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.68 |
Piotroski F-Score | n/a |